3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Hematologic Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Syndrome
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
HIV Infections
1
Fatigue
1
Endometrial Neoplasms
1
Dyspnea
1
Disease
1
Crohn Disease
1
Cough
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Rituximab
12
Cyclophosphamide
12
Biopsy
12
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
fludarabine
7
Lenalidomide
7
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
fludarabine phosphate
4
X-Rays
4
Tacrolimus
4
Mycophenolic Acid
4
Doxorubicin
4
Busulfan
4
venetoclax
3
ibrutinib
3
glofitamab
3
acalabrutinib
3
Whole-Body Irradiation
3
Vincristine
3
GSK2636771
3
Etoposide
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Educational Status
×
30 days
×
Clear all
No trials found.